Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-09

Clinical Trial Update: Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial at Virginia Commonwealth University is evaluating adding antibiotics to the upfront treatment regimen for colorectal cancer; recruitment is ongo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Colorectal Cancer, CRC | Phase 2 | Status: RECRUITING